Copenhagen, Denmark; December 1, 2005 - Genmab A/S (CSE: GEN) has decided to increase its share capital by 14,150 shares as a consequence of the exercise of employee warrants.

The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following prices per share of nominally DKK 1: 2,150 shares at DKK 33.70, 500 shares at DKK 51.50 and 11,500 shares at DKK 116.00. Proceeds to the company are approximately DKK 1.4 mio (approx. USD 225,000). The increase corresponds to approx. 0.04 % of the company’s share capital.

The new shares are ordinary shares without any special rights and are freely transferable negotiable instruments. The new shares carry full right to dividends payable for the current accounting year. The new shares will be listed on the Copenhagen Stock Exchange after registration with the Danish Commerce and Companies Agency. Genmab A/S’ current share capital amounts to DKK 33,093,948 and will after the capital increase be DKK 33,108,098. The capital increase is expected to be finalized shortly.